Neurimmune AG

Name: Neurimmune AG
Telephone: +41 44 755 46 23

Swiss Biotech Association

Member

Neurimmune is a biopharmaceutical company translating human immune memory into transformative antibody therapeutics. Neurimmune discovered aducanumab, a human monoclonal antibody targeting amyloid beta for the treatment of Alzheimer's disease, and licensed it to Biogen.

Facts & figures

Type of organization

Private company
Year of foundation

2006
Number of employees in Switzerland

50-149

Key business

Core competencies

You may also be interested in

Bavarian Nordic Berna GmbH

Bavarian Nordic is a fully integrated vaccine company focused on the development, manufacturing and commercialization of life-saving vaccines. Our manufacturing site for oral vaccines is located in Thörishaus, 15 km southwest of Bern.
3174 Thörishaus

Member

Altorfer Engineering GmbH

Altorfer Engineering is a contractor and consulting company with expertise in providing engineering and project management services, due diligence assessments as well as technology transfer for aseptic drug product and biologics processes.
6300 Zug

Member

ATLyphe AG

ATLyphe is a Swiss biotech startup with the goal of developing antibody-based solutions engaging T cells for precision immunotherapy. We aim to not only provide less toxic and more precise treatments for current patients but also increase the total number of patients eligible to receive the therapy.
8006 Zürich

Member